Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11806369
Exosomes and miRNA to treat glaucoma
granted -
US 11806318
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
granted -
US 11807636
IRAK degraders and uses thereof
granted -
US 11806360
Compositions and methods for treating transthyretin (TTR) mediated amyloidosis
granted -
US 11806406
Virus-like particle conjugates for diagnosis and treatment of tumors
granted -
US 11807629
Polymorphs of Selinexor
granted -
US 11806367
Methods of treating lysosomal disorders
granted -
US 11807649
Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2
granted -
US 11806429
Film formulations containing dexmedetomidine and methods of producing them
granted -
US 11806408
Methods and compositions for treating cone-rod retinal dystrophy
granted -
US 11807605
Human plasma kallikrein inhibitors
granted -
US 11806400
Injectable ibuprofen formulation
granted -
US 11806389
Compositions and methods for treating central nervous system injury
granted -
US 11806385
Biomarkers for monitoring immune transformation
granted -
US 11806353
Methods of treating liver disorders or lipid disorders with a THR-beta agonist
granted -
US 11807682
M971 chimeric antigen receptors
granted -
US 11806337
Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof
granted -
US 11807646
4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19)
granted -
US 11806432
Compositions, methods and uses for thermally stable multi-targeted antigens
granted -
US 11806334
Non-sedating dexmedetomidine treatment regimens
granted -
US 11807853
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 11806354
Pharmaceutical compositions comprising meloxicam
granted -
US 11806336
Methods and compositions for treatment of epileptic disorders
granted -
US 11807674
Hepcidin analogues and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.